Edwards Lifesciences Corp (EW)vsKoninklijke Philips NV ADR (PHG)
EW
Edwards Lifesciences Corp
$83.98
+0.57%
HEALTHCARE · Cap: $48.42B
PHG
Koninklijke Philips NV ADR
$26.16
-0.68%
HEALTHCARE · Cap: $24.89B
Smart Verdict
WallStSmart Research — data-driven comparison
Koninklijke Philips NV ADR generates 183% more annual revenue ($17.83B vs $6.30B). EW leads profitability with a 17.4% profit margin vs 5.0%. PHG appears more attractively valued with a PEG of 0.32. EW earns a higher WallStSmart Score of 61/100 (C+).
EW
Buy61
out of 100
Grade: C+
PHG
Buy51
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+69.9%
Fair Value
$263.84
Current Price
$83.98
$179.86 discount
Margin of Safety
+3.8%
Fair Value
$33.33
Current Price
$26.16
$7.17 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 31.2%
16.7% revenue growth
Growing faster than its price suggests
Reasonable price relative to book value
Generating 1.3B in free cash flow
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
1.1% revenue growth
ROE of 7.8% — below average capital efficiency
5.0% margin — thin
Earnings declined 0.5%
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Operating Margin, Revenue Growth. Profitability is solid with margins at 17.4% and operating margin at 31.2%. Revenue growth of 16.7% demonstrates continued momentum.
Bull Case : PHG
The strongest argument for PHG centers on PEG Ratio, Price/Book, Free Cash Flow. PEG of 0.32 suggests the stock is reasonably priced for its growth.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 45.4x leaves little room for execution misses.
Bear Case : PHG
The primary concerns for PHG are Revenue Growth, Return on Equity, Profit Margin.
Key Dynamics to Monitor
EW profiles as a growth stock while PHG is a value play — different risk/reward profiles.
EW carries more volatility with a beta of 0.94 — expect wider price swings.
EW is growing revenue faster at 16.7% — sustainability is the question.
PHG generates stronger free cash flow (1.3B), providing more financial flexibility.
Bottom Line
EW scores higher overall (61/100 vs 51/100), backed by strong 17.4% margins and 16.7% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Koninklijke Philips NV ADR
HEALTHCARE · MEDICAL DEVICES · USA
Koninklijke Philips NV is a healthcare technology company in North America, Greater China and internationally. The company is headquartered in Amsterdam, the Netherlands.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?